Skip to main content
OpenTrials

Clinical trial condition

Arthritis, Gouty

Explore clinical trials studying Arthritis, Gouty. Study availability and eligibility vary by location and protocol.

33 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Arthritis, Gouty trial results

Completed

Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients

NCT05119686

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Arthrosi Investigative Site Gilbert, Arizona, United States
  • Arthrosi Investigative Site Sun City, Arizona, United States
  • Arthrosi Investigative Site Tucson, Arizona, United States
  • Arthrosi Investigative Site Miami, Florida, United States
View all 23 locations
View Trial Details
Completed

β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)

NCT01470989

Conditions
Acute Gouty Arthritis Flares, Arthritis, Arthritis, Gouty, +11 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Norwalk, California, United States
  • Novartis Investigative Site Pasadena, California, United States
View all 56 locations
View Trial Details
Completed

Long Term Study of Canakinumab (ACZ885) in Patients With Gout

NCT00927810

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Novartis Investigative site Seattle, Washington, United States
  • Novartis Investigative site Capital Federal Buenos Aires, Argentina
  • Novartis Investigative site Jette, Belgium
  • Novartis Investigative site Barranquilla, Colombia
View all 45 locations
View Trial Details
Completed

Celebrex In Acute Gouty Arthritis Study

NCT00549549

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Pfizer Investigational Site Glendale, Arizona, United States
  • Pfizer Investigational Site Mesa, Arizona, United States
  • Pfizer Investigational Site Paradise Valley, Arizona, United States
  • Pfizer Investigational Site Peoria, Arizona, United States
View all 81 locations
View Trial Details
Completed

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

NCT00819585

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Talbert Medical Group Huntington Beach, California, United States
  • San Diego Arthritis & Osteoporosis Medical clinic San Diego, California, United States
  • Health Awareness Jupiter, Florida, United States
  • East-West Medical Research institute Honolulu, Hawaii, United States
View all 89 locations
View Trial Details
Completed

AMPED Outcomes Registry of Post-ED Pain Management

NCT01626235

Conditions
Agnosia, Arthritis, Arthritis, Gouty, +44 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • LSU Medical Center New Orleans, Louisiana, United States
  • University of Mississippi Medical Center Jackson, Mississippi, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

NCT00663169

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Novartis Investigator Site Birmingham, Alabama, United States
  • Novartis Investigator Site New Brunswick, New Jersey, United States
  • Novartis Investigator Site Lausanne, Switzerland
  • Novartis Investigator Site Glasgow, United Kingdom
View Trial Details

Related conditions